Effects on Blood Pressure and Central Sympathetic Nerve Traffic by SGLT2-inhibition With Empagliflozin Compared to Hydrochlorothiazide in Patients With Type 2 Diabetes Mellitus
Latest Information Update: 05 Nov 2021
Price :
$35 *
At a glance
- Drugs Empagliflozin (Primary) ; Hydrochlorothiazide
- Indications Hypertension; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 13 Jul 2020 Status changed from active, no longer recruiting to completed.
- 02 Jul 2020 Status changed from recruiting to active, no longer recruiting.
- 17 Jan 2020 Planned End Date changed from 15 Sep 2019 to 15 Dec 2020.